While Basaglar can be prescribed for both type 1 and type 2 diabetes in adults and also in children aged 6+, Ozempic, however, is only approved for type 2 diabetes & isnt an option for people with type 1 diabetes TL;DR Basaglar (insulin glargine) and Ozempic (semaglutide) treat type 2 diabetes through completely different mechanisms Basaglar is a long acting basal insulin injected daily that directly replaces insulin your body lacks while Ozempic is a GLP 1 receptor agonist injected weekly that enhances your bodys natural insulin production Key differences: Ozempic promotes weight loss (10-15%) while Basaglar often causes weight gain Ozempic reduces A1C by 1.4-1.8% vs Basaglars 0.8-1.5%
Lower doses were tested as well: 1mg achieved 8.7%, 4mg achieved 17.1%, and 8mg achieved 22.8%
It binds to the GHRH receptors in the anterior pituitary gland to stimulate the pulsatile secretion of growth hormone
Dudek KA, Dion-Albert L, Lebel M, LeClair K, Labrecque S, Tuck E, et al
Method: A pre-filled pen device with a small, hidden needle designed for ease and comfort